Company Overview of Mission Pharmacal Company, Inc.
Mission Pharmacal Company, Inc., a pharmaceutical company, develops and manufactures prescription medications and over-the-counter products in therapeutic areas of women's health, pediatric, urology, and dermatology. The company’s products include CitraNatal, a prescription prenatal vitamin that provides nutrition for preconception, pregnancy, and lactation in various formulations customized for individual patient needs; Urocit-K, a potassium citrate indicated for the management of renal tubular acidosis with calcium stones, hypocitraturic calcium oxalate nephrolithiasis of etiology, and uric acid lithiasis with or without calcium stones; and Texacort, a prescription therapy for the relief o...
10999 Interstate Highway 10 West
San Antonio, TX 78230-1355
Founded in 1946
Key Executives for Mission Pharmacal Company, Inc.
President of Commercial Operations
Senior Director of Consumer Marketing
Compensation as of Fiscal Year 2014.
Mission Pharmacal Company, Inc. Key Developments
Retrophin, Inc. Enters into a First Amendment to Trademark License and Supply Agreement with Mission Pharmacal Company
Jul 29 14
On July 28, 2014, Retrophin, Inc. entered into a First Amendment to Trademark License and Supply Agreement with Mission Pharmacal Company to amend the Trademark License & Supply Agreement, made effective as of May 29, 2014, between Mission and the Company. The First Amendment revises the territory covered by the Agreement, at no additional cost or expense, to include the United States and Canada, as allowed by Canadian regulations for compassionate use.
Mission Pharmacal Introduces New and Improved Version of Top-Selling Prescription Prenatal Vitamin, Citranatal Harmony
Mar 27 14
Mission Pharmacal Company announced the availability of a new, patented dual-iron version of its premier prenatal vitamin, CitraNatal Harmony, the first and only single-pill prescription supplement with calcium citrate. The new, improved product features Ferr-Ease, a patented blend of ferrous fumarate, a rapidly absorbing iron salt, and carbonyl iron, known for its gentle, prolonged absorption. The new CitraNatal Harmony formulation provides a full spectrum of essential vitamins and minerals without causing the gas and discomfort associated with some supplements. New, gentler CitraNatal Harmony is now available in the United States as a prescription supplement to improve nutrition for women prior to conception, throughout pregnancy, and in the postnatal period. CitraNatal Harmony is safe for use by mothers who are breastfeeding their babies. CitraNatal Harmony also offers mothers and babies essential vitamins and minerals, including 250 mg of DSM's life'sDHA, in one convenient, easy-to-swallow, vanilla-scented gel cap. DHA is the essential fatty acid recommended for brain and eye development. It has been shown to support increased birth weight and size and enhance visual and cognitive abilities. The vitamin also contains a stool softener to help ease constipation that often accompanies pregnancy.
Mission Pharmacal Company Introduces Portfolio of Proven Products into Long-Term Care Environment
Mar 20 14
Mission Pharmacal Company is introducing a portfolio of proven products into the long-term care environment. The company has always held steadfast to its dedication to provide the high quality healthcare medications and treatments for a wide range of conditions and diseases. The long-term care initiative capitalizes on the resources at Mission that have fueled the tremendous expansion and growth the company has been experiencing in recent years. In the nursing home environment, the medical needs of the elderly can offer significant challenges. For example, one of the products that Mission recently introduced to the LTC market is BINOSTO(R), a prescription product that is an effervescent alendronate sodium oral solution for the treatment of osteoporosis in post menopausal women and treatment to increase bone mass in men with osteoporosis. While osteoporosis is prevalent among nursing home residents, so is dysphagia, the inability or difficulty patients can have swallowing pills. Bisphosphonates are the most common medications prescribed for osteoporosis treatment. Patients who are unable to swallow pills could not easily take alendronate treatment for their osteoporosis. BINOSTO has changed that. It is the first and only alendronate sodium tablet that can be dissolved in water to create a buffered solution for the treatment of osteoporosis. According to the CDC, 50% of nursing home residents will fall at least once this year. Naturally, good bone health is foremost on the minds of the health care teams and taking calcium and vitamin D is a proven standard of treatment. Each serving of Mission's Calcet Creamy Bites provides calcium and vitamin D for better bone health. In addition, each piece contains 500 mg elemental calcium from calcium citrate, the most readily-absorbed form of calcium, along with 400 IU vitamin D3. Dry mouth or xerostomia is a very common condition in the LTC setting. On average, nursing home residents can be on 8 to 12 medications per day which can increase the possibility of side effects like dry mouth. Another new Mission product, Aquoral, is a unique and effective prescription oral spray that moistens and lubricates the mouth for up to four hours with no known side effects. A single dose is just two sprays into the mouth; no spitting or rinsing required. More information on this innovative therapy including full prescribing information is available at aquoral.com. By bringing all of these products together, with more to follow, Mission is working with LTC providers to help healthcare professionals improve quality of care for their patients.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|